KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) EPS (Basic) (2018 - 2024)

Historic EPS (Basic) for BioNTech SE (BNTX) over the last 4 years, with Q4 2024 value amounting to $240277.8.

  • BioNTech SE's EPS (Basic) rose 706.68% to $240277.8 in Q4 2024 from the same period last year, while for Dec 2024 it was $240277.8, marking a year-over-year increase of 706.68%. This contributed to the annual value of -$638981.5 for FY2024, which is 1534589079.76% down from last year.
  • As of Q4 2024, BioNTech SE's EPS (Basic) stood at $240277.8, which was up 706.68% from $241585.4 recorded in Q3 2024.
  • Over the past 5 years, BioNTech SE's EPS (Basic) peaked at $241585.4 during Q3 2024, and registered a low of $81938.8 during Q3 2023.